Arthrosamid is a polyacrylamide hydrogel developed by Contura International Ltd. as a long-lasting intra-articular injection approved in Europe for the treatment of knee osteoarthritis (OA). The treatment has the potential to change the present care pathway for managing osteoarthritis, which affects around one in four adults in Ireland aged over 601 (over 400,000 people)2 and current treatments are not long lasting or involve invasive knee replacement surgery. Despite a large suffering population, there has been very little innovation in the range of osteoarthritis treatments on offer to meaningfully help patients – until now.

Knee Injections for Osteoarthritis: Comparing Costs, Availability, and Patient Experiences in the UK
Explore the types, costs, and effectiveness of knee injections for osteoarthritis in the UK, including steroid, hyaluronic acid, hydrogel, and PRP therapies. Understand their availability on the NHS versus private care, typical patient experiences, side effects, and the latest research insights. Learn how these treatments differ from rheumatoid arthritis injections and what to expect during your knee injection journey to manage pain and improve mobility effectively.
